Thrombocytosis: Adverse effect of heparin treatment;La thrombocytose: Un effet secondaire méconnu de l'héparinothérapie

Presse Medicale

Volumn 35, Issue 1 I, 2006, Pages 58-60

  Camou, Fabrice ^a   Viallard, Jean François ^a   Caubet, Olivier ^a   Pellegrin, Jean Luc ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ENOXAPARIN; HEPARIN; HYDROXYUREA; TINZAPARIN; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; MALE; MYELOPROLIFERATIVE DISORDER; REMISSION; THROMBOCYTHEMIA; THROMBOCYTOSIS; THROMBOSIS; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; FRANCE; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS; TIME;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTICOAGULANTS; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; FRANCE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MYELOPROLIFERATIVE DISORDERS; PLATELET COUNT; PLATELET FACTOR 4; THROMBOCYTOSIS; THROMBOPOIESIS; TIME FACTORS;

EID: 33644871849     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74521-3     Document Type: Article

References (8)

1. Rizzieri DA, Wong WM, Gockerman JP. Thrombocytosis associated with low molecular weight heparin. Ann Intern Med. 1996; 125: 157.
2. Bunting RW, Doppelt SH, Lavine L. Extreme thrombocytosis after orthopaedic surgery. J Bone Joint Surg. 1991; 73: 687-8.
3. Ziaja K, Simka M, Krupowies A, Dugaj M, Ludyga T. Thrombocytosis after prophylactic administration of enoxaparin: unexpected findings in a polish prospective multicenter trial on the efficacity and safety of enoxaparin in the prevention of postoperative thromboembolism. Int Angiol. 1999; 18: 65-9.
4. Liautard C, Correa Nunes AM, Vial T, Chatillon F, Guy C, Ollagnier M et al. Low molecular weight heparins and thrombocytosis. Ann Pharmacother. 2002; 36: 1351-4.
5. Bellucci S, Han ZC, Caen J. Effets de l'héparine sur la mégacaryocytopoïèse. Ann Med Interne. 1997; 148: 150-3.
6. Shen ZX, Basara N, Xi D Caen J, Maffrand JP, Pascal M, Petitou M et al. Fraxiparin, a low molecular weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice. Br J Haematol. 1994; 88: 608-12.
7. Han ZC, Bellucci S, Shen ZX, Maffrand JP, Pascal M, Petitou M et al. Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growths regulators. J Cell Physiol. 1996; 168: 97-104
8. Schafer AI. Current concepts: thrombocytosis. N Engl J Med. 2004; 350: 1211-9.